During the past decade, East Texas Medical Center Cancer Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East Texas Medical Center Cancer Institute" #1 sponsor was "Radiation Therapy Oncology Group" with 14 trials, followed by "Genentech, Inc." with 4 trials sponsored, "Novartis Pharmaceuticals" with 2 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored and "Puma Biotechnology, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East Texas Medical Center Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "East Texas Medical Center Cancer Institute" are "Prostate Cancer" (4 trials), "Lung Cancer" (3 trials), "Brain and Central Nervous System Tumors" (2 trials), "Head and Neck Cancer" (2 trials) and "Metastatic Cancer" (2 trials). Many other conditions were trialed in "East Texas Medical Center Cancer Institute" in a lesser frequency.

Most popular intervention types in "East Texas Medical Center Cancer Institute" are "Drug" (16 trials), "Radiation" (13 trials), "Procedure" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (10 trials), "quality-of-life assessment" (3 trials), "cisplatin" (2 trials), "iodine I 125" (2 trials) and "3D-CRT" (1 trials). Other intervention names were less common.

The vast majority of trials in "East Texas Medical Center Cancer Institute" are 17 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "East Texas Medical Center Cancer Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in East Texas Medical Center Cancer Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in East Texas Medical Center Cancer Institute, 4 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".